With increasing interest in high-LET in clinical practice, the involvement of the p53 pathway in the different radiobiological responses to HNSCC, depending on the type of ionizing radiation chosen, could argue for the use of heavy ion therapy, especially for HPV + cases. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.